USPTO serial 99551797
BIOMEDAI
Status 602
- Filing date
- Dec 16, 2025
- Status date
- Aug 7, 2026
- Registration date
- —
- Examiner
- MASON, JARED MICHAEL
Need help with BIOMEDAI?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Owner
Biomed AI, Inc.
San Jose, CA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Therapeutic pharmaceutical for the treatment of Alzheimer's disease, obesity and cardiovascular diseases | ACTIVE | Nov 7, 2024 |
| 042 | Computer programming services, namely, use artificial applications for drug discovery | ACTIVE | Nov 7, 2024 |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Aug 7, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Aug 7, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Apr 23, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 23, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Apr 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Apr 20, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Apr 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Dec 16, 2025 | NWAP | NEW APPLICATION ENTERED |